Literature DB >> 6813900

The presence of 7-hydroxychlorpromazine in CSF of chloropromazine-treated patients.

G Alfredsson, M Lindberg, G Sedvall.   

Abstract

7-Hydroxychlorpromazine (7-OHCPZ) has been identified and quantified in CSF from chlorpromazine (CPZ)-treated schizophrenic patients. The level of the metabolite in CSF was similar to that of CPZ. In serum the amount of 7-OHCPZ was about 30% of CPZ. The concentration of 7-OHCPZ in csf was positively and significantly correlated to the serum level.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813900     DOI: 10.1007/bf00432774

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.

Authors:  T Kolakowska; D H Wiles; M G Gelder; A S McNeilly
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

2.  Effect of chlorpromazine and some of its metabolites on the accumulation of homovanilic acid in brain of mice.

Authors:  J Dailey; G Sedvall; B Sjöquist
Journal:  J Pharm Pharmacol       Date:  1972-07       Impact factor: 3.765

3.  The possible role of metabolites in therapeutic response to chlorpromazine treatment.

Authors:  G Sakalis; T L Chan; S Gershon; S Park
Journal:  Psychopharmacologia       Date:  1973-09-28

4.  Effect of chlorpromazine and some of its metabolites on synthesis and turnover of catecholamines formed from 14 C-tyrosine in mouse brain.

Authors:  H Nybäck; G Sedvall
Journal:  Psychopharmacologia       Date:  1972

5.  Correlation between plasma concentrations of chlorpromazine and clinical response.

Authors:  L Rivera-Calimlim; T Gift; H A Nasrallah; R J Wyatt; L Lasagna
Journal:  Commun Psychopharmacol       Date:  1978

6.  Levels of chlorpromazine and its active metabolites in rat brain and the relationship to central monoamine metabolism and prolactin secretion.

Authors:  G Alfredsson; F A Wiesel; P Skett
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

7.  Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis.

Authors:  O T Phillipson; J M McKeown; J Baker; A F Healey
Journal:  Br J Psychiatry       Date:  1977-08       Impact factor: 9.319

8.  A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSF.

Authors:  G Alfredsson; B Wode-Helgodt; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

9.  Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.

Authors:  B Wode-Helgodt; S Borg; B Fyrö; G Sedvall
Journal:  Acta Psychiatr Scand       Date:  1978-08       Impact factor: 6.392

10.  Chlorpromazine levels and the outcome of treatment in schizophrenic patients.

Authors:  P R May; T Van Putten; D J Jenden; C Yale; W J Dixon
Journal:  Arch Gen Psychiatry       Date:  1981-02
View more
  2 in total

Review 1.  Plasma level monitoring of antipsychotic drugs. Clinical utility.

Authors:  S G Dahl
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

2.  Metabolism of levomepromazine in man.

Authors:  P A Hals; S G Dahl
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Jan-Mar       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.